Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection | Citedby Results | Journal of Parasitology

Skip to Main Content

Skip Nav Destination

Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection

J Parasitol (2020) 106 (3): 323–333.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease

Daniele Cavalcante Gomes
Thayse Silva Medeiros
Eron Lincoln Alves Pereira
João Felipe Oliveira da Silva
Johny W. de Freitas Oliveira
Matheus de Freitas Fernandes-Pedrosa
Marcelo de Sousa da Silva
Arnóbio Antônio da Silva-Júnior

International Journal of Molecular Sciences (2023) 24 (18): 13778.

Formulation of benznidazole-lipid nanocapsules: Drug release, permeability, biocompatibility, and stability studies

Eva C. Arrua
Olga Hartwig
Brigitta Loretz
Xabier Murgia
Duy-Khiet Ho
Guillaume Bastiat
Claus-Michael Lehr
Claudio J. Salomon

International Journal of Pharmaceutics (2023) 642: 123120.

Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy

Eva C. Arrua
Olga Hartwig
Brigitta Loretz
Héctor Goicoechea
Xabier Murgia
Claus-Michael Lehr
Claudio J. Salomon

Colloids and Surfaces B: Biointerfaces (2022) 217: 112678.

Review on Experimental Treatment Strategies Against Trypanosoma cruzi

Ana Lia Mazzeti
Patricia Capelari-Oliveira
Maria Terezinha Bahia
Vanessa Carla Furtado Mosqueira

Journal of Experimental Pharmacology (2021) Volume 13: 409.